Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-11-12 4:15 pm Purchase | 13D | ATEA PHARMACEUTICALS INC AVIR | Bain Capital Life Sciences Fund II L.P. | 4,783,102 5.8% | 4,783,102 (New Position) | View |
| 2020-08-13 4:16 pm Purchase | 13G | ARYA SCIENCES ACQUISITION CORP ARYA | Bain Capital Life Sciences Fund II L.P. | 891,429 5.8% | 891,429 (New Position) | View |
| 2020-07-20 4:16 pm Purchase | 13G | THERAPEUTICS ACQUISITION CORP RACA | Bain Capital Life Sciences Fund II L.P. | 891,429 6.3% | 891,429 (New Position) | View |
| 2020-04-17 5:26 pm Purchase | 13D | MERSANA THERAPEUTICS INC MRSN | Bain Capital Life Sciences Fund II L.P. | 3,071,566 5.2% | 3,071,566 (New Position) | View |
| 2019-12-30 4:56 pm Purchase | 13D | SAVARA INC SVRA | Bain Capital Life Sciences Fund II L.P. | 5,128,593 13% | 5,128,593 (New Position) | View |